Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia

INTRODUCTION: This phase 2 trial evaluated the safety, tolerability, and feasibility of repeated infusions of the plasma fraction GRF6019 in mild‐to‐moderate Alzheimer's disease. METHODS: In this randomized, double‐blind, dose‐comparison trial, 47 patients were randomized 1:1 to receive daily i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement (N Y)
Main Authors: Hannestad, Jonas, Koborsi, Katie, Klutzaritz, Vicki, Chao, Whitney, Ray, Rebecca, Páez, Antonio, Jackson, Sam, Lohr, Scott, Cummings, Jeffrey L., Kay, Gary, Nikolich, Karoly, Braithwaite, Steven
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7744029/
https://ncbi.nlm.nih.gov/pubmed/33344754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/trc2.12115
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados